Source: European Medicines Agency (EU) Revision Year: 2024 Publisher: Recordati Rare Diseases, Tour Hekla, 52, avenue du Général de Gaulle, F-92800 Puteaux, France
CYSTAGON 50 mg hard capsules.
Pharmaceutical Form |
---|
Hard capsule. White, opaque hard capsules with CYSTA 50 on the body and RECORDATI RARE DISEASES on the cap. |
Each hard capsule contains 50 mg of cysteamine (as mercaptamine bitartrate).
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Mercaptamine |
Mercaptamine reduces corneal cystine crystal accumulation acting as a cystine-depleting agent by converting cystine to cysteine and cysteine-cysteamine mixed disulfides. |
List of Excipients |
---|
Capsule content: Microcrystalline cellulose Capsule shell: Gelatin |
HDPE bottles of 100 and 500 hard capsules. A desiccant unit containing black activated carbon and silica gel granules is included in the bottle.
Not all pack sizes may be marketed.
Recordati Rare Diseases, Tour Hekla, 52, avenue du Général de Gaulle, F-92800 Puteaux, France
EU/1/97/039/001 (100 hard capsules per bottle)
EU/1/97/039/002 (500 hard capsules per bottle)
Date of first authorisation: 23 June 1997
Date of latest renewal: 23 June 2007
Drug | Countries | |
---|---|---|
CYSTAGON | Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.